Form 8-K - Current report:
SEC Accession No. 0001193125-23-107449
Filing Date
2023-04-20
Accepted
2023-04-20 08:11:35
Documents
48
Period of Report
2023-04-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d453291d8k.htm   iXBRL 8-K 26743
2 EX-99.1 d453291dex991.htm EX-99.1 35645
7 GRAPHIC g453291ex99_1s10g1.jpg GRAPHIC 535184
8 GRAPHIC g453291ex99_1s11g1.jpg GRAPHIC 534053
9 GRAPHIC g453291ex99_1s12g1.jpg GRAPHIC 481656
10 GRAPHIC g453291ex99_1s13g1.jpg GRAPHIC 503785
11 GRAPHIC g453291ex99_1s14g1.jpg GRAPHIC 574534
12 GRAPHIC g453291ex99_1s15g1.jpg GRAPHIC 492532
13 GRAPHIC g453291ex99_1s16g1.jpg GRAPHIC 485592
14 GRAPHIC g453291ex99_1s17g1.jpg GRAPHIC 519408
15 GRAPHIC g453291ex99_1s18g1.jpg GRAPHIC 541938
16 GRAPHIC g453291ex99_1s19g1.jpg GRAPHIC 360035
17 GRAPHIC g453291ex99_1s1g1.jpg GRAPHIC 550160
18 GRAPHIC g453291ex99_1s20g1.jpg GRAPHIC 595863
19 GRAPHIC g453291ex99_1s21g1.jpg GRAPHIC 592582
20 GRAPHIC g453291ex99_1s22g1.jpg GRAPHIC 425636
21 GRAPHIC g453291ex99_1s23g1.jpg GRAPHIC 484040
22 GRAPHIC g453291ex99_1s24g1.jpg GRAPHIC 614589
23 GRAPHIC g453291ex99_1s25g1.jpg GRAPHIC 475324
24 GRAPHIC g453291ex99_1s26g1.jpg GRAPHIC 493997
25 GRAPHIC g453291ex99_1s27g1.jpg GRAPHIC 502969
26 GRAPHIC g453291ex99_1s28g1.jpg GRAPHIC 438998
27 GRAPHIC g453291ex99_1s29g1.jpg GRAPHIC 485411
28 GRAPHIC g453291ex99_1s2g1.jpg GRAPHIC 701527
29 GRAPHIC g453291ex99_1s30g1.jpg GRAPHIC 453838
30 GRAPHIC g453291ex99_1s31g1.jpg GRAPHIC 484899
31 GRAPHIC g453291ex99_1s32g1.jpg GRAPHIC 477441
32 GRAPHIC g453291ex99_1s33g1.jpg GRAPHIC 64999
33 GRAPHIC g453291ex99_1s34g1.jpg GRAPHIC 294420
34 GRAPHIC g453291ex99_1s3g1.jpg GRAPHIC 483987
35 GRAPHIC g453291ex99_1s4g1.jpg GRAPHIC 397379
36 GRAPHIC g453291ex99_1s5g1.jpg GRAPHIC 412854
37 GRAPHIC g453291ex99_1s6g1.jpg GRAPHIC 445273
38 GRAPHIC g453291ex99_1s7g1.jpg GRAPHIC 562923
39 GRAPHIC g453291ex99_1s8g1.jpg GRAPHIC 581956
40 GRAPHIC g453291ex99_1s9g1.jpg GRAPHIC 485337
  Complete submission text file 0001193125-23-107449.txt   23012111

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA snse-20230420.xsd EX-101.SCH 3871
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snse-20230420_def.xml EX-101.DEF 13726
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE snse-20230420_lab.xml EX-101.LAB 22780
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snse-20230420_pre.xml EX-101.PRE 14694
42 EXTRACTED XBRL INSTANCE DOCUMENT d453291d8k_htm.xml XML 5124
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39980 | Film No.: 23831454
SIC: 2834 Pharmaceutical Preparations